Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Biotechnol Bioeng. 2015 Oct 27;113(5):930–943. doi: 10.1002/bit.25851

Figure 5.

Figure 5

CRISPR-based antimicrobials. (A) Targeting the bacterial genome leads to potent and sequence-specific cell killing. (B) Bacteriophages can be employed to deliver plasmids encoding CRISPR-Cas9, leading to targeted killing or plasmid clearance.